Varicella Virus Vaccine Market Size, Share, Growth 2023
The Fortune Business Insights adds Global "Varicella Virus Vaccine Market" 2023-2029 report that offers an total content of the assiduity with brief analysis, data maps, numbers, statistics that help take business opinions, company biographies and further.
The Complete report specifies the historical, present,
and projected size of the market from the standpoint of both value and volume.
SWOT and Value Chain Analysis are utilized to gauge the market. The market is
very fragmented by type and application, with sales market share and rate of
growth by type, application.
Also report compromises in-depth analysis covering key
regional trends, market dynamics, and provides country-level market size of the
worldwide Varicella Virus Vaccine Market.
Get a Free Sample Research PDF :
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/104688
About Varicella Virus Vaccine Market Growth and
Size
In August 2020, during the pandemic GSK announced the
launch of DTC campaign for Shingrix vaccine targeted against geriatric
population for vaccination against varicella –zoster virus.In December 2019,
Sinovac Biotech Ltd announced the approval from China National Medical Products
Administration (NMPA) for its varicella vaccine indicated against
varicella-zoster virus for children aged 1 to 12 years old.
The global Varicella Virus Vaccine Market was
valued at USD million in 2022 and is anticipated to reach USD million by 2029,
witnessing a CAGR of during the forecast period 2023-2029. The influence of
COVID-19 and the Netherlands-Ukraine War were considered while estimating
market sizes.
North American Varicella Virus Vaccine Market is estimated to increase
from USD million in 2023 to reach USD million by 2029, at a CAGR of during the
forecast period of 2023 through 2029.
Asia-Pacific Varicella Virus Vaccine Market is estimated to increase
from USD million in 2023 to reach USD million by 2029, at a CAGR of during the
forecast period of 2023 through 2029.
Varicella Virus Vaccine Market Research is spread
across 100+ pages
and provides exclusive data, information, vital statistics, trends and
competitive landscape details in this niche sector.
Major Players in Varicella Virus Vaccine Market
2023 are:
The major companies in the global varicella virus
vaccines market report includes GlaxoSmithKline Plc, Merck & Co. Inc,
Sanofi, Mitsubishi Tanabe Pharma Corporation, Novo Medi Sciences Pvt Ltd,
Takeda Pharmaceutical Company Limited, GC Pharma, Bio-Med Pvt Ltd, and others.
For More Information :
https://www.fortunebusinessinsights.com/varicella-virus-vaccine-market-104688
About Us:
Fortune Business Insights™ delivers accurate
data and innovative corporate analysis, helping organizations of all sizes make
appropriate decisions. We tailor novel solutions for our clients, assisting
them to address various challenges distinct to their businesses. Our aim is to
empower them with holistic market intelligence, providing a granular overview
of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd
U.S.: +1 424 253 0390
U.K.: +44 2071 939123
APAC: +91 744 740 1245
Comments
Post a Comment